Seagen Inc Dividend yield

Seagen Inc is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Seagen Inc is a company from USA, and his stocks are publicly traded.

Seagen Inc stock dividend

Seagen Inc paid a total dividend of 0 million USD last year, for a market value of 38,741 millions (Market Cap 28,826 millions). Seagen Inc dividend per share is 0.00 USD, and his stock market price 206.07 USD.

According to the chart below where dividend yield is displayed, Seagen Inc, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from USA, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Seagen Inc might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Seagen Inc stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high USA dividend stocks list.

Seagen Inc Dividend Payout

About the ability of Seagen Inc to maintain his current dividend of USD 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Seagen Inc payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Seagen Inc, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Seagen Inc Dividend History

Below you will find a table with the historical evolution of Seagen Inc's dividend stock, both in percentage and in USD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	USD	Paypout	Shares*
Present	0.00%	0.00	0.00%	188
2022	0.00%	0.00	0.00%	184

*In millions

Seagen Inc Stock performance

Finally, last moth Seagen Inc showed a return of 7.50% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 33.60% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.